lactation

Dysphoric Milk Ejection Reflex: Recognizing a Poorly Understood Breastfeeding Challenge

Dysphoric Milk Ejection Reflex causes brief, intense waves of dysphoria at milk letdown, often misinterpreted as postpartum depression, and can undermine breastfeeding and maternal well-being.

By |2026-07-16T09:34:00-04:00June 29th, 2026|Breastfeeding & Medications, Postpartum Psychiatric Disorders|Comments Off on Dysphoric Milk Ejection Reflex: Recognizing a Poorly Understood Breastfeeding Challenge

Zuranolone and Breastfeeding: Emerging Data and Clinical Implications

Treatment with zuranolone, a novel oral antidepressant for postpartum depression, raises important questions for breastfeeding individuals. While recent studies show minimal transfer into breast milk, we do not yet have enough information to recommend breastfeeding while taking zuranolone.

By |2025-10-09T10:59:51-04:00August 13th, 2025|Breastfeeding & Medications, Postpartum Depression|Comments Off on Zuranolone and Breastfeeding: Emerging Data and Clinical Implications

Essential Reads: Breastfeeding and Anti-Epileptic Drugs

While data are limited regarding AEDs and breastfeeding, it appears that none of the AEDs are excreted at high levels into the breast milk, nor have they been associated with high rates of adverse events in the nursing infant.

By |2025-06-26T09:07:30-04:00August 10th, 2022|Anti-Epileptic Drugs, Breastfeeding & Medications, Essential Reads, Prevalence & Risk Factors|Comments Off on Essential Reads: Breastfeeding and Anti-Epileptic Drugs

Essential Reads: Alcohol and Breastfeeding

We frequently receive questions regarding the safety of drinking alcohol while breastfeeding.  While the harmful effects of alcohol use during pregnancy are well known, we have much less information regarding the consequences of alcohol [...]

By |2020-12-15T10:55:54-04:00December 16th, 2020|Alcohol, Breastfeeding & Medications, Essential Reads, Perinatal Substance Use|Comments Off on Essential Reads: Alcohol and Breastfeeding

Case Series: Mirtazapine (Remeron) in Pregnancy and Lactation

While we have adequate data to support the use of SSRI antidepressants during pregnancy, there is less data regarding other classes of antidepressants.  A new case series documents the outcomes of infants exposed to mirtazapine (Remeron).

By |2016-07-20T13:46:56-04:00February 23rd, 2015|Antidepressants, Breastfeeding & Medications, Outcomes, Pregnancy & Medications|Comments Off on Case Series: Mirtazapine (Remeron) in Pregnancy and Lactation
Go to Top